Wang Ming-Dong, Franklin Vivian, Sundaram Meenakshi, Kiss Robert S, Ho Kenneth, Gallant Michel, Marcel Yves L
Lipoprotein and Atherosclerosis Research Group, University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7, Canada.
J Biol Chem. 2007 Aug 3;282(31):22525-33. doi: 10.1074/jbc.M700326200. Epub 2007 Jun 5.
Niemann-Pick type C1 (Npc1) protein inactivation results in lipid accumulation in late endosomes and lysosomes, leading to a defect of ATP binding cassette protein A1 (Abca1)-mediated lipid efflux to apolipoprotein A-I (apoA-I) in macrophages and fibroblasts. However, the role of Npc1 in Abca1-mediated lipid efflux to apoA-I in hepatocytes, the major cells contributing to HDL formation, is still unknown. Here we show that, whereas lipid efflux to apoA-I in Npc1-null macrophages is impaired, the lipidation of endogenously synthesized apoA-I by low density lipoprotein-derived cholesterol or de novo synthesized cholesterol or phospholipids in Npc1-null hepatocytes is significantly increased by about 1-, 3-, and 8-fold, respectively. The increased cholesterol efflux reflects a major increase of Abca1 protein in Npc1-null hepatocytes, which contrasts with the decrease observed in Npc1-null macrophages. The increased Abca1 expression is largely post-transcriptional, because Abca1 mRNA is only slightly increased and Lxr alpha mRNA is not changed, and Lxr alpha target genes are reduced. This differs from the regulation of Abcg1 expression, which is up-regulated at both mRNA and protein levels in Npc1-null cells. Abca1 protein translation rate is higher in Npc1-null hepatocytes, compared with wild type hepatocytes as measured by [(35)S]methionine incorporation, whereas there is no difference for the degradation of newly synthesized Abca1 in these two types of hepatocytes. Cathepsin D, which we recently identified as a positive modulator of Abca1, is markedly increased at both mRNA and protein levels by Npc1 inactivation in hepatocytes but not in macrophages. Consistent with this, inhibition of cathepsin D with pepstatin A reduced the Abca1 protein level in both Npc1-inactivated and WT hepatocytes. Therefore, Abca1 expression is specifically regulated in hepatocytes, where Npc1 activity modulates cathepsin D expression and Abca1 protein translation rate.
尼曼-皮克C1型(Npc1)蛋白失活会导致晚期内体和溶酶体中脂质蓄积,进而致使巨噬细胞和成纤维细胞中ATP结合盒转运蛋白A1(Abca1)介导的脂质外流至载脂蛋白A-I(apoA-I)的过程出现缺陷。然而,Npc1在Abca1介导的脂质外流至apoA-I过程中在肝细胞(对高密度脂蛋白形成起主要作用的细胞)中的作用仍不清楚。在此我们表明,虽然Npc1基因敲除巨噬细胞中脂质外流至apoA-I的过程受损,但Npc1基因敲除肝细胞中由低密度脂蛋白衍生胆固醇或从头合成胆固醇或磷脂对内源性合成的apoA-I进行的脂化作用分别显著增加了约1倍、3倍和8倍。胆固醇外流增加反映出Npc1基因敲除肝细胞中Abca1蛋白大量增加,这与Npc1基因敲除巨噬细胞中观察到的减少情况形成对比。Abca1表达增加主要是转录后水平的,因为Abca1 mRNA仅略有增加且Lxrα mRNA未改变,并且Lxrα靶基因减少。这与Abcg1表达的调节不同,后者在Npc1基因敲除细胞中在mRNA和蛋白水平均上调。与野生型肝细胞相比,通过[³⁵S]甲硫氨酸掺入法测定,Npc1基因敲除肝细胞中Abca1蛋白翻译速率更高,而在这两种类型的肝细胞中,新合成的Abca1的降解没有差异。组织蛋白酶D,我们最近将其鉴定为Abca1的正向调节剂,在肝细胞中通过Npc1失活在mRNA和蛋白水平均显著增加,但在巨噬细胞中未增加。与此一致,用胃蛋白酶抑制剂A抑制组织蛋白酶D降低了Npc1失活和野生型肝细胞中的Abca1蛋白水平。因此,Abca1表达在肝细胞中受到特异性调节,其中Npc1活性调节组织蛋白酶D表达和Abca1蛋白翻译速率。